Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
+3.1%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$63.2B
AUM Growth
+$2.99B
(+5%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
2.66%
Top 10 Holdings %
Top 10 Hldgs %
20.27%
Holding
4,222
New
203
Increased
2,047
Reduced
1,654
Closed
188
Top Buys
| 1 |
Capital Group Dividend Value ETF
CGDV
|
$48.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$45.4M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$39.4M |
| 4 |
T. Rowe Price Capital Appreciation Equity ETF
TCAF
|
$33.9M |
| 5 |
Broadcom
AVGO
|
$32M |
Top Sells
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
$35.8M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
$29.2M |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
$25.1M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$24.8M |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
$22.8M |
Sector Composition
| 1 | Technology | 13.04% |
| 2 | Financials | 5.25% |
| 3 | Consumer Discretionary | 4% |
| 4 | Healthcare | 3.99% |
| 5 | Industrials | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3676
ADMA Biologics
ADMA
$3.92B
| $176K | ﹤0.01% |
15,710
+2,950
| +23% | +$33K |
|
3677
C4 Therapeutics
CCCC
$193M
| $176K | ﹤0.01% |
38,097
-905
| -2% | -$4.18K |
|
3678
Real Brokerage
REAX
$1.06B
| $176K | ﹤0.01% |
43,371
-774
| -2% | -$3.14K |
|
3679
Asana
ASAN
$3.25B
| $175K | ﹤0.01% |
12,507
-372
| -3% | -$5.21K |
|
3680
Core Scientific, Inc. Tranche 1 Warrants
CORZW
$764M
| $175K | ﹤0.01% |
38,804
| – | – |
|
3681
Lemonade
LMND
$3.91B
| $174K | ﹤0.01% |
10,551
-901
| -8% | -$14.9K |
|
|
ECF
3682
Ellsworth Growth & Income Fund
ECF
$153M
| $173K | ﹤0.01% |
20,958
-1,183
| -5% | -$9.77K |
|
3683
Globalstar
GSAT
$4.81B
| $173K | ﹤0.01% |
10,273
+6,353
| +162% | +$107K |
|
3684
Nuveen Municipal Income
NMI
$101M
| $173K | ﹤0.01% |
17,665
+929
| +6% | +$9.1K |
|
|
RFMZ
3685
RiverNorth Flexible Municipal Income Fund II
RFMZ
$313M
| $173K | ﹤0.01% |
12,211
+148
| +1% | +$2.1K |
|
3686
Stratasys
SSYS
$876M
| $173K | ﹤0.01% |
+20,589
| New | +$173K |
|
3687
Lexicon Pharmaceuticals
LXRX
$392M
| $170K | ﹤0.01% |
101,134
+5,950
| +6% | +$10K |
|
3688
ProShares UltraPro Short QQQ
SQQQ
$2.29B
| $170K | ﹤0.01% |
4,104
-49
| -1% | -$2.03K |
|
3689
BlackRock Floating Rate Income Trust
BGT
$317M
| $168K | ﹤0.01% |
13,140
+194
| +1% | +$2.48K |
|
3690
Inspirato
ISPO
$38.9M
| $167K | ﹤0.01% |
47,577
| – | – |
|
3691
Red Robin
RRGB
$110M
| $167K | ﹤0.01% |
22,022
+1,573
| +8% | +$11.9K |
|
3692
GSI Technology
GSIT
$85.5M
| $166K | ﹤0.01% |
62,670
-520
| -0.8% | -$1.38K |
|
3693
Nuveen California Municipal Value Fund
NCA
$285M
| $166K | ﹤0.01% |
19,137
+3,540
| +23% | +$30.7K |
|
3694
Adaptive Biotechnologies
ADPT
$1.91B
| $165K | ﹤0.01% |
45,628
-333
| -0.7% | -$1.2K |
|
|
EFR
3695
Eaton Vance Senior Floating-Rate Fund
EFR
$344M
| $164K | ﹤0.01% |
12,529
+574
| +5% | +$7.51K |
|
|
GLQ
3696
Clough Global Equity Fund
GLQ
$139M
| $164K | ﹤0.01% |
23,453
+306
| +1% | +$2.14K |
|
3697
TFS Financial
TFSL
$3.84B
| $163K | ﹤0.01% |
12,888
-845
| -6% | -$10.7K |
|
3698
Civista Bancshares
CIVB
$407M
| $162K | ﹤0.01% |
10,433
+63
| +0.6% | +$978 |
|
|
GUG
3699
Guggenheim Active Allocation Fund
GUG
$528M
| $162K | ﹤0.01% |
10,833
+344
| +3% | +$5.14K |
|
3700
Sibanye-Stillwater
SBSW
$6.38B
| $161K | ﹤0.01% |
37,058
+8,756
| +31% | +$38K |
|